Latest filing: Vivanza Biosciences Ltd - 530057 - Board Meeting Intimation for The Consideration And Approval Of The Quarterly Financial Result Ended On 30Th June, 2026.
ObservedCompany dossier
Vivanza Biosciences
BSE:VIVANZA · ISIN INE984E01035
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Vivanza Biosciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Material events
Open timeline →What changed recently
Observed
Source filing Vivanza Biosciences Ltd - 530057 - Board Meeting Intimation for The Consideration And Approval Of The Quarterly Financial Result Ended On 30Th June, 2026.
BSE · financial results
Observed
Source filing Vivanza Biosciences Ltd - 530057 - Declaration Pursuant To Regulation 33(3)(D) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
BSE · exchange filing
Observed
Source filing Vivanza Biosciences Ltd - 530057 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 09Th July, 2026.
BSE · exchange filing
Observed
Source filing Vivanza Biosciences Ltd - 530057 - Appointment of Company Secretary and Compliance Officer
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →Awaiting shareholding
No reconciled records in this module yet
A shareholding summary has not been reconciled.